文献速递乳房整形与再造美容整形

比较POLYTECH MESMO与Motiva Ergonomix乳房假体:聚焦移位问题,一位外科医生329例患者经验

Comparison of POLYTECH MESMO and Motiva Ergonomix Breast Implants With Focus on Displacement Issues: A Single Surgeon's Experience with 329 Patients.
PubMed 文献 · Aesthet Surg J · 2024-01-01

本研究由同一外科医生连续纳入329例接受Motiva Ergonomix或POLYTECH MESMO假体隆乳的患者,按假体类型分组并用生存分析评估并发症。结果显示POLYTECH MESMO组结局更有利,Motiva Ergonomix组移位相关问题(尤其下移)发生率令人担忧,且无主要并发症优势。

要点

  • 329例中POLYTECH MESMO组185例(56.2%),Motiva Ergonomix组144例(43.8%),两组中位随访均为8个月。
  • 42例(12.8%)发生至少一种并发症,其中Motiva Ergonomix组26例(P = .013)。
  • 下移在Motiva Ergonomix组15例 vs POLYTECH MESMO组0例(P < .001);再手术4.2% vs 0.5%(P = .046)。

核心结论

  • POLYTECH MESMO假体提供了更有利的结局;Motiva Ergonomix假体在术后最初几年显示出令人担忧的移位问题发生率,且在其他主要并发症方面无优势。

研究设计与样本

  • 同一外科医生既往手术放置Motiva Ergonomix和POLYTECH MESMO假体的连续患者被纳入,按假体类型分为2组,通过生存分析评估并发症发生。

主要发现

  • 共收集329例患者数据,POLYTECH MESMO组185例(56.2%),Motiva Ergonomix组144例(43.8%),两组中位随访均为8个月。
  • 42例女性(12.8%)经历至少一种并发症,其中26例属于Motiva Ergonomix亚组(P = .013)。
  • 该期间最常见的并发症为移位问题,下移在Motiva Ergonomix组明显更常见:15例 vs POLYTECH MESMO组0例(P < .001)。
  • 7例患者需要再手术,Motiva Ergonomix假体患者更常需要再手术(4.2% vs 0.5%;P = .046)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nanotextured breast implants (classified as smooth implants by the latest ISO 14607:2018) have been described as possibly reducing major textured implant-related complications such as capsular contracture and breast implant-associated anaplastic large cell lymphoma. On the other hand, microtextured breast implants benefit from an optimal safety profile based on a much larger body of literature. OBJECTIVES: The aim of this study was to directly compare the incidence of complications between Motiva Ergonomix (Establishment Labs Holdings, Inc., Alajuela, Costa Rica) and POLYTECH MESMO (POLYTECH Health & Aesthetics GmbH, Dieburg, Germany) breast implants, especially regarding the displacement issues that might arise after breast augmentation. METHODS: Consecutive patients who previously underwent surgery by the same physician for placement of Motiva Ergonomix and POLYTECH MESMO implants were included in this study. They were divided into 2 groups according to the type of implant. The onset of complications was assessed through survival analysis. RESULTS: Data were collected from 329 patients, 185 (56.2%) with POLYTECH MESMO and 144 (43.8%) with Motiva Ergonomix implants. The median follow-up was 8 months for both groups. Of the 42 women (12.8%) who experienced at least one complication, 26 belonged to the Motiva Ergonomix subgroup (P = .013). The most represented complications during this period resulted from displacement issues, with a clear prevalence of bottoming out in the Motiva Ergonomix cohort: 15 cases vs 0 cases in the POLYTECH MESMO cohort (P < .001). For 7 patients, a reoperation was required, more frequently for patients with Motiva Ergonomix implants (4.2% vs 0.5%; P = .046). CONCLUSIONS: POLYTECH MESMO devices provided a more favorable outcome. Motiva Ergonomix devices revealed a concerning incidence of displacement issues during the first postsurgery years, with no advantage over other major complications.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Montemurro P. Comparison of POLYTECH MESMO and Motiva Ergonomix Breast Implants With Focus on Displacement Issues: A Single Surgeon's Experience with 329 Patients. Aesthet Surg J. 2024. PMID: 38547508. doi:10.1093/asj/sjae071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。